Articles | Open Access | DOI: https://doi.org/10.37547/TAJMSPR/Volume02Issue09-17

The Use Of Daily Continuous Glucose Monitoring (Chmg) In Clinical Practice

Narbaev Abduhamid Namazovich , P.h.D. Assistant Department Of Internal Medicine With Endocrinology, Samarqand State Medical Institute,Samarqand, Republik Of Uzbekistan
Togaeva Gulnora Siddiqovna , Assistant Department Of Internal Medicine With Endocrinology, Samarqand State Medical Institute,Samarqand, Republik Of Uzbekistan
Davranova Aziza Davranovna , Assistant Department Of Internal Medicine With Endocrinology, Samarqand State Medical Institute,Samarqand, Republik Of Uzbekistan

Abstract

Type 1 diabetes mellitus is a disease in which the highest rates of premature mortality and early disability of patients are observed, which is caused by the onset of the disease at an early age, the instability of the course of type 1 diabetes and the threat of acute and chronic complications.  The goals of type 1 diabetes mellitus treatment are its compensation, prevention of the risk of complications when normoglycemia is reached and stabilized.

Keywords

Diabetes mellitus, glucose

References

Ametov A. S. Prospects for the treatment of diabetes mellitus in the next 10 years. / Russian medical journal. -2005.-T. 13. Ne6. - P. 288-203

Ametov A.S., Avakova K.A .. An integrated approach to patient management, receiving insulin pump therapy. Russian Medical Journal. - 2007, vol. 15, No27, -C. 2050-2052

Balabolkin M.I., Petunina N.A., Telnova M.E., Klebanova E.M., Antonova K.V. "The role of insulin therapy in compensating for diabetes mellitus." // Russian Medical Journal. -2007, No25.-С.2-7.

Dedov II, Shestakova M.B. Algorithms for specialized medical care for patients with diabetes mellitus. Moscow, 2006

Tiselko A.V. Using a system of round-the-clock glucose monitoring and pump insulin therapy in patients with diabetes. Lecture, 2005, St. Petersburg.

American Diabetes Association. Continuous Subcutaneous Insulin Infusion. // Diabetes Care. -2005, Vol. 25, Suppl. 1.- P. 116

Aussedat B, Dupire-Angel M, Gifford R, Klein JC, Wilson GS, Reach G: Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring. // Am J Physiol Endocrinol Metab. 2007, N 278. E716-E728

Fiallo-Scharer R; Diabetes Research in Children Network Study Group: Eight-point glucose testing versus the continuous ghucose monitoring system in evaluation of glucemic control in type 1 diabetes. // J Clin Endocrinol Metab, No. 90.- P: 3387-3391, 2005

G. S. Togaeva, Clinical And Biochemical Parameters Of Patients With Type 2 Diabetes Who Were Trained At The School Of Self- Control. // JOURNAL OF BIOMEDICINE AND PRACTICE SPECIAL ISSUE-2. P-131-136, 2020

Article Statistics

Copyright License

Download Citations

How to Cite

Narbaev Abduhamid Namazovich, Togaeva Gulnora Siddiqovna, & Davranova Aziza Davranovna. (2020). The Use Of Daily Continuous Glucose Monitoring (Chmg) In Clinical Practice. The American Journal of Medical Sciences and Pharmaceutical Research, 2(09), 82–85. https://doi.org/10.37547/TAJMSPR/Volume02Issue09-17